Clinical Trial Update: Study Evaluating Safety of 13-Valent Pneumococcal Conjugate Vaccine in Healthy Elderly Subjects [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the safety of the 13-valent pneumococcal conjugate vaccine (Prevnar 13) in healthy elderly subjects; the study has completed a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Infections

Drugs mentioned

• Prevnar 13 (pneumococcal conjugate vaccine)

Snippet

Sponsor: Pfizer | Conditions: Pneumococcal Infections | Phase 3 | Status: COMPLETED | Results posted: 2011-09-16